Europe — EMA
Mevir (Brivudine)
GNH USA supplies Mevir (Brivudine), a nucleoside analogue antiviral for the treatment of herpes zoster (shingles). Request a quote for global supply.
Request sourcing
What is Brivudine?
Brivudine, the active ingredient in Mevir, is a nucleoside analogue antiviral presented as an oral tablet for oral use. It is indicated for the treatment of herpes zoster (shingles) in adults and works by inhibiting viral DNA synthesis.
GNH USA supplies Mevir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Brivudine used for?
Mevir is a nucleoside analogue antiviral indicated for the management of herpes zoster, a reactivation of varicella‑zoster virus.
Herpes zoster (shingles): Reduces viral replication and accelerates lesion healing in adults with acute shingles.
What are the side effects of Brivudine?
Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Fatigue: feeling of tiredness. - Dyspepsia: indigestion or upper abdominal discomfort. - Dizziness: occasional light‑headedness.
Serious or Rare Side Effects: - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hematologic abnormalities: neutropenia, thrombocytopenia, or anemia. - Anaphylaxis: rare but potentially life‑threatening allergic response. - Renal impairment: worsening kidney function in susceptible patients.
What precautions apply to Brivudine?
Before initiating therapy, consider the following precautions: - Renal impairment: avoid or adjust dose in severe renal dysfunction. - Hepatic dysfunction: use with caution in patients with liver disease. - Hypersensitivity: discontinue if allergic reactions occur. - Concomitant fluoropyrimidines: avoid co‑administration due to increased toxicity. - Blood monitoring: periodic complete blood counts are advised. - Store below 25°C: keep in the original pack, protect from moisture.
What does Brivudine interact with?
Brivudine may interact with several medicines; awareness of the interaction level is essential.
Major Interactions (Avoid): - Fluoropyrimidines (e.g., 5‑fluorouracil, capecitabine): co‑administration can cause severe, potentially fatal toxicity. - Other nucleoside antivirals: may increase risk of overlapping adverse effects.
Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation parameters. - Oral contraceptives: reduced hormonal efficacy, consider alternative contraception. - Antacids: may affect brivudine absorption, separate dosing by at least 2 hours.



